Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABRAFENIB\TRAMETINIB vs DACOMITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABRAFENIB\TRAMETINIB vs DACOMITINIB: Safety Overview

Metric DABRAFENIB\TRAMETINIB DACOMITINIB
Total FAERS Reports 113 682
Deaths Reported 10 325
Death Rate 8.8% 47.7%
Hospitalizations 17 168
Average Patient Age 55.1 yrs 64.0 yrs
% Female Patients 49.5% 52.0%
FDA Approval Date N/A Sep 27, 2018
Manufacturer N/A Pfizer Laboratories Div Pfizer Inc
Route N/A ORAL
Marketing Status N/A Prescription